K120466

Substantially Equivalent

VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)

Applicant: Nanosphere, Inc.
Product code: NTI
Advisory panel: Clinical Toxicology
Date received: 2012-02-15
Decision date: 2012-11-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Northbrook, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.